Browse studies
Find your next paid study
26 recruiting studies matching your filters
Phase 1
A Phase I Trial of Revumenib in Combination With 7+3 (7 Days of Cytarabine and 3 Days of Daunorubicin) + Midostaurin Induction Chemotherapy for the Frontline Treatment of NPM1 and FLT3 Mutated AML
This research is being conducted to determine a safe and effective dose of revumenib that can be given in combination with standard induction (initial therapy …
Acute Myeloid LeukemiaAML, AdultAML With Gene Mutations+2 more
Estimated
~$10 – $7,500
Richard Stone, MDNCT06313437
Investigating Phenotypic, Epigenetic, and NeuroGenetic Traits in Rare and Ultra-rare Neurodevelopmental Disorders
Rare genetic neurodevelopmental disorders, such as Syt-1 or Baker Gordon Syndrome (BAGOS) arise from mutations in genes essential for brain development and fun…
Baker Gordon SyndromeRare Neurodevelopmental ConditionsRare Neurogenetic Conditions+6 more
Estimated
~$10 – $750
University of Missouri-ColumbiaNCT07329257